There’s been an explosion of interest in women’s health recently. The category, deemed ‘femtech’ by some, is currently a $700m market that’s expected to boom to more than $1 billion by 2025. Of course, women’s health isn’t new, so what, exactly, is different about today's momentum? That’s the question we asked in the latest episode of  “License to Accelerate: Perspectives on the Future of Health” that features Jess Graham, chief marketing officer at Hologram Sciences; Bulbul Hooda, brand creator and chief marketing officer at Vella Bioscience; and Michelle Webb who leads the health practice at Allison+Partners. The conversation is moderated by PRovoke Media executive editor Aarti Shah.  03:08      More about Hologram Sciences and Vella Bioscience

06:38      Why we should examine the use of ‘femtech’ 

07:21      Medical terms vs. euphemisms for women’s health 

10:16      Social media restrictions on feminine health 

13:49      How to build trust around such intimate offerings 

17:48     Inclusive storytelling on women’s health

21:26     How data is driving storytelling on women’s health 

24:16     Combating ageism against women 

27:10     Where is the conversation headed?

29:40     How to stand out in such a crowded, buzz-generating space?